ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Frank E. Schmidt, Jr
Charles O. Murphy
John Parker Gott
Robert A. Guyton
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, F. E.
Right arrow Articles by Guyton, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, F. E., Jr
Right arrow Articles by Guyton, R. A.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1996;62:1691-1696
© 1996 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Leukocyte Depletion of Blood Cardioplegia Attenuates Reperfusion Injury

Frank E. Schmidt, Jr, MD, Malcolm J. MacDonald, MD, Charles O. Murphy, MD, W. Morris Brown, III, MD, John Parker Gott, MD, Robert A. Guyton, MD

Division of Cardiothoracic Surgery, Emory University School of Medicine, The Carlyle Fraser Heart Center, Emory/Crawford Long Hospital, Atlanta, Georgia


    Abstract
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Background. Leukocytes are associated with myocardial injury during reperfusion after ischemia. Short periods of leukocyte depletion during reperfusion result in persistent attenuation of postischemic myocardial dysfunction.

Methods. Leukocyte depletion was examined in a canine model of regional myocardial ischemia and reperfusion. The extracorporeal circuit and cardioplegia circuits underwent leukocyte depletion by mechanical filtration. Animals were instrumented for baseline global function before 90-minute occlusion of the left anterior descending coronary artery. Global function during ischemia and at 5, 30, 60, and 90 minutes after a 60-minute cardioplegic arrest using continuous blood cardioplegia was assessed in leukocyte-depleted (n = 9) and control (n = 10) groups.

Results. No significant difference between groups was seen for systemic leukocyte counts, global function, or water content. Endothelial function was significantly protected as assessed by response to both calcium ionophore (endothelial-dependent, receptor-independent relaxation: leukocyte-depleted, 72% ± 19% of endothelin-induced constriction versus control, 46% ± 14%; p < 0.05) and acetylcholine (endothelial-dependent, receptor-dependent relaxation: leukocyte-depleted, 83% ± 11% versus control, 44% ± 15%; p < 0.05).

Conclusions. Leukocyte-mediated endothelial reperfusion injury can be attenuated by leukocyte depletion during reperfusion.


    Introduction
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
See also page 1696.

Reperfusion of ischemic myocardium results in additional damage superimposed upon that caused by ischemia alone [1]. Prior studies have demonstrated that reperfusion injury results in endothelial dysfunction [2], expression of endothelial and leukocyte adhesion molecules [3], complement activation [4], production of free radicals [5], and the activation and accumulation of leukocytes [6]. Because reperfusion injury can be ameliorated by inhibition of the mediators of leukocyte sequestration [79] and because leukocyte depletion of the reperfusate attenuates reperfusion injury [8, 10, 11], the polymorphonuclear leukocyte has been implicated as the major effector of reperfusion injury [12]. Interestingly, brief periods of leukocyte depletion during reperfusion impart lasting protective effect even if leukocytes are reintroduced [13]. Cardiac operations using continuous blood cardioplegia afford a unique clinical opportunity to control both the conditions of reperfusion and the composition of the reperfusate after a period of acute ischemia. This study was designed to determine whether leukocyte depletion of both the cardiopulmonary bypass (CPB) circuit and cardioplegic solution results in protection of global mechanical function or microvascular reactivity.


    Material and Methods
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Dirofilaria-negative dogs were used as study animals in one of two randomly assigned experimental groups that either did or did not employ leukocyte filters. After premedication with 4 mg/kg morphine sulfate the animals were anesthetized using 20 mg/kg pentobarbital and endotracheally intubated. The femoral artery was cannulated for arterial blood gas analysis and pressure monitoring. The femoral vein was cannulated for central venous access. A median sternotomy was performed, the azygos vein ligated, and the pericardium opened. The heart was then instrumented with a left ventricular conductance catheter (Webster Laboratories, Baldwin Park, CA) inserted via the aortic root into the left ventricular cavity. A left ventricular micromanometer (Millar Instruments, Houston, TX) was inserted through a stab wound in the left ventricular apex. Catheter placement was checked by fluoroscopy. An ultrasonic flowmeter (Transonic Instruments, Inc, Ithaca, New York) was placed on the ascending aorta. Baseline ventricular function data were obtained by occluding the inferior vena cava to alter preload. Pressure and volume data were obtained, which allowed determination of the slope of the preload recruitable strokework relationship (PRSW). The left anterior descending coronary artery (LAD) was identified just distal to the first diagonal artery and occluded with a snare after systemic heparinization. Ventricular function data were also obtained after 10 and 45 minutes of ischemia. The left subclavian artery was used for arterial inflow for CPB. Bicaval cannulation was used for venous return.

Dirofilaria-positive dogs were used as a source of homologous blood to prime the CPB circuit. Cardiopulmonary bypass was begun at 75 minutes of ischemia, and the animals were cooled to 28°C. The aorta was cross-clamped and the heart arrested with antegrade administration of 4:1 blood-crystalloid cardioplegia containing a final concentration of 20 mEq/L potassium chloride. A coronary sinus catheter was then placed and retrograde delivery of an 8 mEq/L potassium chloride blood cardioplegic solution was begun and continued throughout the remainder of the cross-clamp period. After a total of 90 minutes of LAD occlusion, the snare was removed. Retrograde delivery was adjusted to maintain a mean perfusion pressure of 40 to 45 mm Hg. Arrest was maintained for 60 minutes, and the animals were rewarmed 10 minutes before cross-clamp removal. The animals were defibrillated as needed and maintained in a beating, nonworking state for 10 additional minutes. Ventricular function data were obtained 5, 30, 60, and 90 minutes after taper from CPB.

In the leukocyte-depleted group, homologous blood from the donor animal was passed through leukocyte-depleting filters (RC-400; Pall, East Hills, NY) as it was infused into the cardiotomy reservoir as part of the prime of the cardiopulmonary bypass circuit. Leukocyte-depleting filters were also incorporated into the arterial line of the bypass circuit (LG-6; Pall) and into the cardioplegia line (BC1; Pall).

Baseline blood samples were taken from both groups before institution of CPB and after 2, 15, 30, 45, and 60 minutes of bypass from the arterial inflow line for determination of leukocyte counts and differentials. Samples were similarly taken 5, 30, 60, and 90 minutes after separation from CPB. In the leukocyte-depleted group, blood samples were also taken before and after the cardioplegia line filter for determination of leukocyte counts.

Left ventricular volume was assessed using the conductance catheter technique. An electrical field was generated within the left ventricular chamber using the dual field method [14]. The measured conductance is related to the volume of the ventricle and the conductivity of the medium by the following equation: Vuc(t) = (L2/s)G(t), where Vuc is the uncorrected conductance derived volume, L is the interelectrode distance, s is the specific conductivity of the medium, and G(t) is the time-varying sum of the segmental conductances plus one-third of the conductance of the first segment. Conductivity of the medium was determined by one of the modules of the signal processor-conditioner (Leycom Sigma 5/DF; Cardiodynamics, Rynsburg, the Netherlands). The catheter was connected to a signal processor-conditioner, which supplied a 20 kHz, 30 mA current to the terminal field generating electrodes. The intervening electrodes of the catheter measured the conductance of five segments, the height of which could be adjusted according to the size of the ventricle.

Data were recorded via an analog-to-digital conversion board (Data Translation, Inc, Marlboro, MA) and processed, stored, and analyzed using an interactive program developed in this laboratory (James M. Bradford, PhD, Computer Assisted Research Laboratory Analysis,&copy; Emory University, 1995). The system was formatted to collect 6-second recordings of 16 channels of physiologic data. The interactive features of this program allowed visual confirmation of the hemodynamic data.

Global left ventricular function was quantitated by assessing the slope of the PRSW. This relationship was obtained by computer integration of the area within the left ventricular pressure-volume loops and plotting this area (stroke work) versus the end-diastolic volume. The PRSW line was obtained as a least squares linear regression of multiple cardiac cycles during acute variation of the preload.

After the last functional evaluation, the heart was rapidly excised and placed in a 4°C buffer solution. Microvascular reactivity was assessed in both the ischemic (LAD distribution) and nonischemic regions (circumflex distribution). Microarterial vessels (100 to 200 µm in diameter) were dissected from branches of the LAD and branches of the left circumflex artery using a 60x (Nikon SMZ-U, Tokyo, Japan) dissecting microscope. Vessels were then placed in an isolated dual-chamber Plexiglas organ chamber and cannulated with dual glass micropipettes (tip measuring 40 to 80 µm in diameter) and secured with 10-0 nylon monofilament suture. Krebs'/HEPES buffer solution warmed to 37°C was continuously circulated through the organ chamber and a 100 mL reservoir. The microvessels were pressurized to 20 mm Hg using a mercury manometer in a no-flow state. The organ chamber was then mounted on the stage of an inverted microscope (Nikon Diaphot Phase Contrast-2) and connected to a video camera (Burle 10W-5050, Lancaster, PA). The vessel image was projected onto a television monitor, and a video dimension analyzer (Living Systems Instrumentation, Burlington, VT) was used to measure the baseline diameter of the lumen. Vessels were allowed to bathe in the organ chamber for 60 minutes before any intervention. Vessels were then preconstricted using endothelin I (1 x 10-10 mol/L to 1 x 10-8 mol/L), yielding constriction to 30% to 40% of the baseline diameter. Acetylcholine, sodium nitroprusside, and calcium ionophore were applied extraluminally to elicit the maximum dilation response from the vessels. After titration to the maximum response from a vessel, a sequential three log increase in concentration was used to demonstrate that the maximum response had been achieved. The initial concentration of all drugs was 1 x 10-10 mol/L. Endothelial preservation was assessed using an endothelial-independent dilating agent (sodium nitroprusside), an endothelial-dependent, receptor-independent agent (calcium ionophore), and an endothelial-dependent, receptor-dependent agent (acetylcholine). The order of administration of acetylcholine and sodium nitroprusside was randomly assigned. Calcium ionophore was administered last due to difficulty in completely washing it from the vessel. Vessels were washed and allowed to equilibrate for 10 to 15 minutes between interventions. Vessels from the ischemic LAD and nonischemic circumflex coronary artery distributions were measured concurrently. Microvascular relaxations are expressed as the percent relaxation of the endothelin-I--induced constriction of the vessel diameter relative to the baseline diameter according to the following equation: [(vessel diameter after application of agonist - preconstricted diameter)/(baseline diameter - preconstricted diameter)].

Myocardial water content was determined from samples of the ischemic LAD distribution and the nonischemic circumflex distribution. Samples were weighed and placed in an oven for desiccation. After a stable weight was obtained the percent water content of the tissue was determined by the following equation: Tissue percent water content = [(wet weight - dry weight)/wet weight] x 100.

Statistical analyses were performed by a biostatistician (R. S. Clark, PhD, Emory University). Analysis of variance with repeated measures was used for all ventricular function, microvascular, and leukocyte data. Myocardial water content was compared using one-way analysis of variance. All values are expressed as mean ± the standard deviation. Significant differences were said to exist at the p less than 0.05 level.


    Results
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
The animals were easily tapered from CPB. The anterior left ventricular wall was dyskinetic in all animals before reperfusion as expected from LAD coronary artery occlusion. Global left ventricular function was not depressed either during the ischemic period or at 90 minutes of reperfusion. The slope of the PRSW increased during the ischemic period an average of 20.3% at 10 minutes of LAD occlusion and 26.5% at 45 minutes. After weaning from CPB, global function as assessed by the slope of the PRSW relationship was comparable with baseline and recovered to levels above baseline in both groups (Table 1Go).


View this table:
[in this window]
[in a new window]
 
Table 1. . Comparison of Global Functiona
 
Systemic leukocyte counts were obtained at 2, 15, 30, 45, and 60 minutes of bypass. In both groups there was a large decrement in circulating leukocytes after the initiation of CPB. The leukocyte counts continued to decrease during the first 30 minutes of CPB but plateaued and remained below baseline levels during the remaining 30 minutes on CPB. In both groups there was a gradual increase in circulating leukocyte levels after CPB, although the levels did not return to baseline. There was no significant difference between the leukocyte-depleted and nondepleted animals in relation to systemic leukocyte counts either before, during, or after CPB (Fig 1Go).



View larger version (19K):
[in this window]
[in a new window]
 
Fig 1. . Total leukocyte counts drawn from the arterial line of the cardiopulmonary bypass circuit expressed as percent of baseline. The ticmark on the x-axis illustrates the end of the 60-minute cardiopulmonary bypass (CPB) period and the beginning of the 90-minute postarrest period. There was no significant difference (NS) in systemic leukocyte counts when leukocyte depletion (LD) was employed.

 
Leukocyte counts were measured in the cardioplegia circuit both before and after filtration. There was a significant decrease in leukocyte counts in the cardioplegia solution after filtration (before filtration, 757 ± 80 cells/mL; after filtration, 41 ± 8 cells/mL; p < 0.05). The efficiency of leukocyte filtration was consistent throughout the cardioplegic period (Fig 2Go). Differential leukocyte counts obtained from the extracorporeal circuit did not reveal preferential filtration of either cell type as there was no significant difference in the ratio of polymorphonuclear leukocytes to lymphocytes in the leukocyte-depleted versus the control group (Fig 3Go).



View larger version (18K):
[in this window]
[in a new window]
 
Fig 2. . Leukocyte counts before the cardioplegia filter and those after it. A significant reduction in leukocyte numbers was demonstrated throughout the cardioplegic period.

 


View larger version (31K):
[in this window]
[in a new window]
 
Fig 3. . Percentage of polymorphonuclear leukocytes (PMN) and lymphcytes (Lymph) at baseline, at the end of the cardiopulmonary bypass (CPB) period, and at the end of the study. There was no significant difference (NS) in the leukocyte composition between the leukocyte-depleted (LD) and control (C) groups.

 
Microvascular reactivity was significantly preserved in the leukocyte-depleted group compared with the control group in the ischemic LAD region (p < 0.05) as assessed by microvascular responses to both endothelium-dependent vasoactive agents (calcium ionophore [Fig 4Go] and acetylcholine [Fig 5Go]). Non--endothelial-dependent relaxation was not different between groups (Fig 6Go). There was no significant difference in microvascular reactivity between groups in the nonischemic circumflex region for either endothelial-dependent or endothelial-independent agonists.



View larger version (20K):
[in this window]
[in a new window]
 
Fig 4. . Microvascular response to the endothelial-dependent, receptor-independent dilator calcium ionophore in the ischemic (left anterior descending artery) region. Percentage of dilation from a preconstricted state is shown on the y-axis and increasing concentration of agent is depicted on the x-axis. A significant difference in response to the agent was demonstrated between the leukocyte-depleted (LD) and control (C) groups.

 


View larger version (19K):
[in this window]
[in a new window]
 
Fig 5. . Microvascular response to the endothelial-dependent, receptor- dependent dilator acetylcholine. Percentage of dilation from a preconstricted state is shown on the y-axis and increasing concentration of agent is depicted on the x-axis. A significant difference was demonstrated in the ischemic region between the leukocyte-depleted (LD) and control groups.

 


View larger version (19K):
[in this window]
[in a new window]
 
Fig 6. . Microvascular response to the endothelial-independent dilator sodium nitroprusside. Percentage of dilation from a preconstricted state is shown on the y-axis and increasing concentration of agent is depicted on the x-axis. No significant difference (NS) was seen between the the response achieved in the leukocyte-depleted (LD) group and the control group.

 

    Comment
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Control of the conditions of reperfusion and the composition of the reperfusate has been shown to have a dramatic effect on preservation of myocardial viability and function after a period of ischemia [15]. The neutrophil is involved in the amplification of the destructive inflammatory activation by its release of cytokines [16]. It has a role in the "no-reflow" phenomenon [17] and releases enzymes that produce oxygen-derived free radicals as well as cytotoxic enzymes responsible for direct myocyte necrosis [18] after ischemia and reperfusion. The endothelium plays a crucial interactive role in this process with impairment of both autocrine and paracrine function resulting in rapid neutrophil adherence and accumulation [19].

Adherence of leukocytes is mediated via surface ligands on both the neutrophils and endothelial cells. These molecules belong to three families: the selectins (E, P, and L), the immunoglobulin superfamily (intercellular adhesion molecule-1), and the integrins (CD11/CD18 complex). These adhesion molecules follow a time-dependent course of expression after reperfusion [20]. P-selectin, which is found on platelets and endothelial cells, is constitutively stored in cytoplasmic granules and is therefore rapidly expressed after ischemia and reperfusion. It binds to cell surface oligosacharrides on the leukocytes and initiates slow rolling of the leukocytes along the endothelium, which allows interaction of the CD11/CD18 integrin on the leukocyte with intercellular adhesion molecule-1 on the endothelium [21]. Weyrich and associates [20] demonstrated this selectin peaks in expression at 20 minutes after onset of reperfusion yet is rapidly downregulated to 30% of its maximum expression by 60 minutes. Inhibition of P-selectin with monoclonal antibody (PB1.3) resulted in a 43% decrease in infarct size versus therapy with nonbinding, nonactive monoclonal antibody (p < 0.01) [21]. E-selectin, the other endothelially based selectin, is not upregulated by reperfusion and does not show substantial expression even at 270 minutes of reperfusion. L-selectin is constitutively stored in leukocyte cytoplasmic granules and is rapidly expressed and shed as the leukocytes become activated [21]. Intercellular adhesion molecule-1 requires gene expression for its upregulation and therefore plays little role before 3 to 4 hours of reperfusion.

Removal of leukocytes from the reperfusate has been shown to limit neutrophil accumulation [12] and translate into superior preservation of myocardial function and reduction of infarct size [10, 22]. Even brief periods of leukocyte depletion (20 minutes) after ischemia/reperfusion protect myocardial viability and preserve myocardial function despite the reintroduction of circulating leukocytes [13]. This implicates P-selectin as a primary determinant of the severity of reperfusion damage after a period of ischemia. Rapid downregulation may explain why temporary leukocyte depletion confers long-lasting protection. Prior studies of the time course of expression of the surface molecules were performed using unmodified whole blood reperfusion. The time course of selectin expression with a regimen of modified cardioplegic reperfusion is unknown and warrants further investigation.

Some preliminary clinical correlation is provided by Sawa and associates [23], who demonstrated a decreased need for inotropic support and decreased serum creatine kinase-MB levels in patients requiring emergency revascularization using leukocyte-depleted cardioplegic reperfusion.

Superior preservation of endothelial function was seen in the leukocyte-depleted group; however, there was no difference in global myocardial function between the two groups. The lack of a significant difference in indices of global function may be due to compensatory hypercontraction of the remote nonischemic myocardium that masks regional dysfunction in measures of global function [24]. This appears to be an intrinsic limitation of global indices of function in a model of regional ischemia. To further investigate this possibility, we placed regional sonomicrometer crystals in the ischemic LAD region and in the nonischemic circumflex region in the last 5 animals (3 leukocyte-depleted, 2 control). All animals showed a significant decrement in regional indices of myocardial performance versus the nonischemic regions. Simultaneous measurement of global myocardial function as measured by the slope of the PRSW relationship demonstrated performance that was improved compared with baseline. The leukocyte-depleted animals showed hypocontractility in the area of ischemia. The ischemic area in the control animals was noncontractile and dyskinetic. Five animals had evaluable regional data, and statistical analysis was not done.

Endothelial microvascular reactivity was superior to control in the leukocyte-depleted group. This supports the earlier observation that leukocyte depletion results in better preservation of postreperfusion coronary blood flow [8], which is consistent with improved preservation of endothelial function. We analyzed vessels that were less than 200 µm in diameter, which represent the resistance vessels in a canine model and thus have an enormous effect on postreperfusion flow [25]. There is also evidence that microvessels show detectable dysfunction earlier than do larger epicardial vessels after this injury [26]. Endothelial function is mediated via endothelium-derived relaxing factor, which is synonymous with nitric oxide. Continued nitric oxide synthesis by the endothelium is important as it inhibits platelet adhesion, neutrophil adhesion, homotypic aggregation, and superoxide formation [19]. Lack of this potent vasodilator may be more important in the no-reflow phenomenon than is extrinsic capillary compression [27] or mechanical plugging [17] as was previously hypothesized. The no-reflow phenomenon may contribute to further injury to damaged myocardium resulting in irreversible necrosis. Preservation of endothelium-derived relaxing factor has also been shown to directly modulate myocardial performance after ischemia and reperfusion [28]. Thus superior preservation of endothelial function has important implications for the effectiveness of reperfusion modification at preventing myocardial necrosis and preserving myocardial performance.

The relative importance of each site of leukocyte depletion was not an end point of this study. The statistically significant decrease in leukocyte counts across the cardioplegia filter may be the result of all three sites of filtration and should not be taken as evidence for the lack of efficacy of systemic filtration or filtration of homologous blood. A recent study by Lazar and colleagues [29] was designed to determine the relative efficacy of site of filtration. Using a model of ischemia/reperfusion injury, they compared wall motion and myocardial necrosis between groups in which systemic leukocyte filtration alone, cardioplegia filtration alone, filtration of both the cardioplegic and systemic circuits, or no filtration was used. They found superior wall motion scores and improved viability in the systemic filtration group [29]. Filtration of the cardioplegia solution alone provided no benefit over control (no filtration) and no added benefit over systemic filtration alone. This implies that the most important site of filtration is the systemic circuit.

The interaction of leukocytes with the endothelium and with myocytes after extravascular migration is a complex physiologic reaction that needs to be more clearly understood before its damaging effects can be prevented. Removal of leukocytes during CPB to alter the composition of the cardioplegic reperfusate improves protection of endothelial microvascular reactivity in a canine model of ischemia and reperfusion. Leukocyte depletion may be an important component of an overall plan to improve both the conditions and the composition of reperfusion to achieve maximal myocardial viability and function in the setting of surgical revascularization for acute myocardial ischemia.


    Footnotes
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 
Presented at the Thirty-Second Annual Meeting of The Society of Thoracic Surgeons, Orlando, FL, Jan 29–31, 1996.

Address reprint requests to Dr Guyton, Carlyle Fraser Heart Center, Emory/Crawford Long Hospital, 550 Peachtree St, Suite 7700, Atlanta, GA 30365-2225.


    References
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 References
 

  1. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edge sword? J Clin Invest 1985;76:1713–9.
  2. Ku DD. Coronary vascular reactivity after acute myocardial ischemia. Science 1982;218:576–8.[Abstract/Free Full Text]
  3. Smith CW. Molecular determinants of neutrophil adhesion [Review]. Am J Respir Cell Mol Biol 1990;2:487–9.
  4. Stahl GL, Reenstra WR, Frendl G. Complement-mediated loss of endothelium-dependent relaxation of porcine coronary arteries. Role of the terminal membrane attack complex. Circ Res 1995;76:575–83.[Abstract/Free Full Text]
  5. McCord JM. Oxygen-derived free radicals in postischemic tissue injury [Review]. N Engl J Med 1985;312:159–63.[Abstract]
  6. Ma XL, Tsao PS, Lefer AM. Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest 1991;88:1237–43.
  7. Lefer DJ, Flynn DM, Phillips ML, Ratcliffe M, Buda AJ. A novel sialyl LewisX analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion. Circulation 1994;90:2390–401.[Abstract/Free Full Text]
  8. Byrne JG, Appleyard RF, Lee CC, et al. Controlled reperfusion of the regionally ischemic myocardium with leukocyte-depleted blood reduces stunning, the no-reflow phenomenon, and infarct size. J Thorac Cardiovasc Surg 1992;103:66–72.
  9. Ma XL, Lefer DJ, Lefer AM, Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 1992;86:937–46.[Abstract/Free Full Text]
  10. Breda MA, Drinkwater DC, Laks H, et al. Prevention of reperfusion injury in the neonatal heart with leukocyte-depleted blood. J Thorac Cardiovasc Surg 1989;97:654–65.[Abstract]
  11. Pearl JM, Drinkwater DC Jr, Laks H, Stein DG, Capouya ER, Bhuta S. Leukocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury. J Surg Res 1992;52:298–308.[Medline]
  12. Litt MR, Jeremy RW, Weisman HF, Winkelstein JA, Becker LC. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury. Circulation 1989;80:1816–27.[Abstract/Free Full Text]
  13. Wilson IC, Gardner TJ, DiNatale JM, et al. Temporary leukocyte depletion reduces ventricular dysfunction during prolonged postischemic reperfusion. J Thorac Cardiovasc Surg 1993;106:805–10.[Abstract]
  14. Steendijk P, van der Velde ET, Baan J. Single and dual excitation of the conductance-volume catheter analysed in a spheroidal mathematical model of the canine left ventricle. Eur Heart J 1992;13(Suppl E):28–34.[Abstract/Free Full Text]
  15. Beyersdorf F, Buckberg GD. Myocardial protection in patients with acute myocardial infarction and cardiogenic shock. Semin Thorac Cardiovasc Surg 1993;5:151–61.[Medline]
  16. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 1995;146:419–28.[Abstract]
  17. Engler RL, Schmid-Schonbein GW, Pavelec RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983;111:98–111.[Abstract]
  18. Inauen W, Granger DN, Meininger CJ, et al. Anoxia-reoxygenation-induced, neutrophil-mediated endothelial cell injury: role of elastase. Am J Physiol 1990;259:H925–31.[Abstract/Free Full Text]
  19. Vinten-Johansen J, Zhao ZQ, Sato H. Reduction in surgical ischemic-reperfusion injury with adenosine and nitric oxide therapy [Review]. Ann Thorac Surg 1995;60:852–7.[Abstract/Free Full Text]
  20. Weyrich AS, Buerke M, Albertine KH, Lefer AM. Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J Leukoc Biol 1995;57:45–55.[Abstract]
  21. Lefer DJ: Myocardial protective actions of nitric oxide donors after myocardial ischemia and reperfusion [Review]. New Horiz 1995;3:105–12.[Medline]
  22. Westlin W, Mullane KM. Alleviation of myocardial stunning by leukocyte and platelet depletion. Circulation 1989;80:1828–36.[Abstract/Free Full Text]
  23. Sawa Y, Matsuda H, Shimazaki Y, et al. Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994;108:1125–31.[Abstract/Free Full Text]
  24. Beyersdorf F. Protection of evolving myocardial infarction and failed PTCA [Review]. Ann Thorac Surg 1995;60:833–8.[Abstract/Free Full Text]
  25. Nellis SH, Liedtke AJ, Whitesell L. Small coronary vessel pressure and diameter in an intact beating rabbit heart using fixed-position and free-motion techniques. Circ Res 1981;49:342–53.[Free Full Text]
  26. Quillen JE, Sellke FW, Brooks LA, Harrison DG. Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation 1990;82:586–94.[Abstract/Free Full Text]
  27. Wiggers CJ. The interplay of coronary vascular resistance and myocardial compression in regulating coronary flow. Circ Res 1954;2:271–9.[Abstract/Free Full Text]
  28. Mohan P, Brutsaert DL, Sys SU. Myocardial performance is modulated by interaction of cardiac endothelium derived nitric oxide and prostaglandins. Cardiovasc Res 1995;29:637–40.[Medline]
  29. Lazar HL, Zhang X, Hamasaki T, et al. Role of leukocyte depletion during cardiopulmonary bypass and cardioplegic arrest. Ann Thorac Surg 1995;60:1745–8.[Abstract/Free Full Text]

Related Article

Discussion
Ann. Thorac. Surg. 1996 62: 1696-1697. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
G. M. Palatianos, G. Balentine, E. G. Papadakis, C. D. Triantafillou, M. I. Vassili, A. Lidoriki, A. Dinopoulos, and G. M. Astras
Neutrophil depletion reduces myocardial reperfusion morbidity
Ann. Thorac. Surg., March 1, 2004; 77(3): 956 - 961.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
E M Heerdt, E J Fransen, J G Maessen, and D S de Jong
Efficacy of leukocyte depletion of residual pump blood
Perfusion, January 1, 2004; 19(1): 3 - 5.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. T.M. Tang, C. Alexiou, J. Hsu, S. V. Sheppard, M. P. Haw, and S. K. Ohri
Leukodepletion reduces renal injury in coronary revascularization: a prospective randomized study
Ann. Thorac. Surg., August 1, 2002; 74(2): 372 - 377.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
G. Asimakopoulos
The inflammatory response to CPB: the role of leukocyte filtration
Perfusion, March 1, 2002; 17(2_suppl): 7 - 10.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. M. Pearl, D. P. Nelson, S. M. Schwartz, and P. B. Manning
First-stage palliation for hypoplastic left heart syndrome in the twenty-first century
Ann. Thorac. Surg., January 1, 2002; 73(1): 331 - 339.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
G Matheis, M Scholz, A Simon, O. Dzemali, and A Moritz
Leukocyte filtration in cardiac surgery: a review
Perfusion, September 1, 2001; 16(5): 361 - 370.
[Abstract] [PDF]


Home page
PerfusionHome page
G Matheis, M Scholz, A Simon, D Henrich, G Wimmer-Greinecker, and A Moritz
Timing of leukocyte filtration during cardiopulmonary bypass
Perfusion, January 1, 2001; 16(1_suppl): 31 - 37.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Rimpilainen, M. Pokela, K. Kiviluoma, V. Anttila, V. Vainionpaa, J. Hirvonen, P. Ohtonen, A. Mennander, E. Remes, and T. Juvonen
Leukocyte filtration improves brain protection after a prolonged period of hypothermic circulatory arrest: A study in a chronic porcine model
J. Thorac. Cardiovasc. Surg., December 1, 2000; 120(6): 1131 - 1140.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. Okazaki, Z.-L. Cao, S. Ohtsubo, M. Hamada, K. Naito, K. Rikitake, M. Natsuaki, and T. Itoh
Leukocyte-depleted reperfusion after long cardioplegic arrest attenuates ischemia-reperfusion injury of the coronary endothelium and myocardium in rabbit hearts
Eur. J. Cardiothorac. Surg., July 1, 2000; 18(1): 90 - 97.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Hayashi, Y. Sawa, M. Nishimura, H. Ichikawa, K. Kagisaki, S. Ohtake, and H. Matsuda
Clinical evaluation of leukocyte-depleted blood cardioplegia for pediatric open heart operation
Ann. Thorac. Surg., June 1, 2000; 69(6): 1914 - 1919.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. D. Sharma, G. Sreeram, T. Erb, H. P. Grocott, and T. F. Slaughter
Leukocyte-Reduced Blood Transfusions: Perioperative Indications, Adverse Effects, and Cost Analysis
Anesth. Analg., June 1, 2000; 90(6): 1315 - 1323.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. E. Jordan, Z.-Q. Zhao, and J. Vinten-Johansen
The role of neutrophils in myocardial ischemia-reperfusion injury
Cardiovasc Res, September 1, 1999; 43(4): 860 - 878.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
S. T Baksaas, H. I Flom-Halvorsen, E. Ovrum, V. Videm, T. E. Mollnes, F. Brosstad, and J. L Svennevig
Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery
Perfusion, March 1, 1999; 14(2): 107 - 117.
[Abstract] [PDF]


Home page
PerfusionHome page
S T Baksaas, V Videm, T E Mollnes, S Tollofsrud, G Hetland, T Pedersen, and J L Svennevig
Leucocyte filtration during cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets
Perfusion, December 1, 1998; 13(6): 429 - 436.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Frank E. Schmidt, Jr
Charles O. Murphy
John Parker Gott
Robert A. Guyton
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, F. E.
Right arrow Articles by Guyton, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, F. E., Jr
Right arrow Articles by Guyton, R. A.
Related Collections
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS